Mitochondrial disorders

Current Opinion in Neurology

Volumn 13, Issue 5, 2000, Pages 527-532

  Schapira, Anthony H V ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B; CYTOCHROME C OXIDASE;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE TOLERANCE; FRIEDREICH ATAXIA; GENOTYPE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROTEIN TARGETING;

ANIMALS; CYTOCHROME-C OXIDASE DEFICIENCY; FRIEDREICH ATAXIA; HIV INFECTIONS; HUMANS; IRON-BINDING PROTEINS; METABOLISM, INBORN ERRORS; MITOCHONDRIAL MYOPATHIES; PAIN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0033787312     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200010000-00004     Document Type: Article

References (59)

1. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects
2. Mitochondrial respiratory chain disorders II: Neurodegenerative disorders and nuclear gene defects
3. The mitochondrial genome: Structure, transcription, translation and replication
4. Paternal inheritance of mitochondrial DNA in mice
5. Elimination of paternal mitochondrial DNA in intraspecific crosses during early mouse embryogenesis
6. Maternal inheritance of mouse mtDNA in interspecific hybrids: Segregation of the leaked paternal mtDNA followed by the prevention of subsequent paternal leakage
7. Evaluation of paternal mitochondrial inheritance in neonates born after intracytoplasmic sperm injection
8. The fate of human sperm-derived mtDNA in somatic cells
9. Electron transfer properties of NADH-ubiquinone reductase in the NA1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON)
10. Platelet mitochondrial function in Leber's hereditary optic neuropathy
11. Leber's hereditary optic neuropathy and complex I deficiency in muscle
12. Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy
13. Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy
14. Functional consequences of the 3460 bp mitochondrial DNA mutation associated with LHON
15. Titrating the effects of mitochondrial complex I impairment in the cell physiology
16. Muscle pain and fatigue
17. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
18. A novel gly29-asp mitochondrial cytochrome b mutation linked to a complex III deficiency in progressive exercise intolerance
19. Mitochondrial encephalomyopathy associated with a nonsense mutation in cytochrome b
20. Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy
21. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobulinuria
22. Muscle pain, fatigue and mitochondriopathies
23. Mitochondrial myopathy caused by long-term zidovudine therapy
24. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
25. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
26. Visceral abdominal-fat accumulation associated with the use of indinavir
27. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance
28. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
29. Multiple symmetrical lipomatosis; abnormalities in complex IV and multiple deletions in mitochondrial DNA
30. Mitochondrial dysfunction in multiple symmetric lipomatosis
31. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
32. HIV nucleoside analogues: New adverse effects on mitochondria?
33. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator
34. Mitochondrial disease in superoxide dismutase 2 mutant mice
35. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice
36. Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: Developing the first mouse model of mitochondrial DNA disease
37. Mitochondrial chloramphenicol-resistant mutants can have deficiencies in energy metabolism
38. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria
39. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene
40. Cytochrome c oxidase deficiency associated with the first stop codon point mutation in mitochondrial DNA
41. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease
42. A mis-sense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy
43. A mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalopathy
44. A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV
45. A mutation in the human heme A: Farnesyltransferase gene (Cox10) causes cytochrome c oxidase deficiency
46. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome
47. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency
48. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene
49. Characterisation of SURF-1 expression and Surf-1 p function in normal and disease conditions
50. Differential features of patients with mutations in two Cox assembly genes, SURF-1 and SCO2
51. Biochemical, genetic and immunoblot analyses of 17 patients with an isolated cytochrome c oxidase deficiency
52. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
53. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
54. Frataxin gene of Friedreich's ataxia is targeted to mitochondria
55. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
56. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
57. Oxidative-phosphorylation defects in liver of patients with Wilson's disease
58. Increased serum transferrin receptor concentrations in Friedreich ataxia
59. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation